Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic Cancer

Overview of attention for article published in Molecular Cancer Research, April 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 6 X users

Readers on

mendeley: 36 Mendeley

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 121,028 followers.

RT @AACR: RT @MCR_AACR: Combined inhibition of Src and #EGFR improves overall survival in mouse model of #PancreaticCancer by targeting #ST…

RT @MCR_AACR: Combined inhibition of Src and #EGFR improves overall survival in mouse model of #PancreaticCancer by targeting #STAT3 signaling and remodelling #TumorStroma, Dosch et al report. @umiamimedicine https://t.co/4IJV5ytDq1 https://t.co/cW4JU8aNHS

Combined inhibition of Src and #EGFR improves overall survival in mouse model of #PancreaticCancer by targeting #STAT3 signaling and remodelling #TumorStroma, Dosch et al report. @umiamimedicine https://t.co/K5bsCbOARt https://t.co/bFebOKtdJ5

#RT @imaging_ms: https://t.co/A83OoyJ8ov https://t.co/GHV6ES45Mu #MSImaging

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.